Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone

被引:19
作者
Sparger, EE [1 ]
Louie, H [1 ]
Ziomeck, AM [1 ]
Luciw, PA [1 ]
机构
[1] UNIV CALIF DAVIS,SCH MED,DEPT MED PATHOL,DAVIS,CA 95616
关键词
D O I
10.1006/viro.1997.8787
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Establishment of infection of animals with a viral clone will be important for investigating viral determinants of pathogenesis and monitoring sequence changes in the viral genome in vivo and may find utility as a means of immunization with live-attenuated virus. To test the efficiency of intramuscular (im) injection of cloned proviral plasmid DNA for establishing feline immunodeficiency virus (FIV) infection in specific pathogen-free (SPF) cats, groups of cats were inoculated by the im route with 300, 100, or 30 mu g of plasmid DNA containing the infectious molecular clone, FIV-pPPR. A fourth group of cats was inoculated intradermally with 30 mu g of FIV-pPPR plasmid DNA. For comparison, a fifth group received 10(3) TCID50 of a live virus stock of FIV-pPPR by intraperitoneal inoculation. Inoculation by im injection with 100 to 300 mu g of infectious FIV-pPPR proviral DNA produced infection detectable by both antiviral antibody and virus isolation from peripheral blood mononuclear cells. Inoculation by im injection with 30 mu g of proviral DNA resulted in infection in two of three inoculated cats. Intradermal injection with 30 mu g of proviral DNA induced infection in one of three cats. Induction of antiviral antibody and viremia was delayed in cats inoculated with 30 mu g compared to cats inoculated with either 100 or 300 mu g of proviral DNA. This study indicates that cloned FIV proviral DNA may replace infectious virion preparations as inocula for pathogenesis and immunization studies. (C) 1997 Academic Press.
引用
收藏
页码:157 / 160
页数:4
相关论文
共 20 条
[1]   DETECTION OF FELINE IMMUNODEFICIENCY VIRUS (FIV) NUCLEIC-ACIDS IN FIV-SERONEGATIVE CATS [J].
DANDEKAR, S ;
BEEBE, AM ;
BARLOUGH, J ;
PHILLIPS, T ;
ELDER, J ;
TORTEN, M ;
PEDERSEN, N .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4040-4049
[2]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587
[3]   THE EFFECT OF AGE ON THE COURSE OF EXPERIMENTAL FELINE IMMUNODEFICIENCY VIRUS-INFECTION IN CATS [J].
GEORGE, JW ;
PEDERSEN, NC ;
HIGGINS, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) :897-905
[4]   Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [J].
Huygen, K ;
Content, J ;
Denis, O ;
Montgomery, DL ;
Yawman, AM ;
Deck, RR ;
DeWitt, CM ;
Orme, IM ;
Baldwin, S ;
DSouza, C ;
Drowart, A ;
Lozes, E ;
Vandenbussche, P ;
VanVooren, JP ;
Liu, MA ;
Ulmer, JB .
NATURE MEDICINE, 1996, 2 (08) :893-898
[5]   Genetic vaccination: The advantages of going naked [J].
Kumar, V ;
Sercarz, E .
NATURE MEDICINE, 1996, 2 (08) :857-859
[6]   RISKS OF HANDLING HIV [J].
LETVIN, NL ;
LORD, CI ;
KING, NW ;
WYAND, MS ;
MYRICK, KV ;
HASELTINE, WA .
NATURE, 1991, 349 (6310) :573-573
[7]   COMPARISON OF 2 HOST-CELL RANGE VARIANTS OF FELINE IMMUNODEFICIENCY VIRUS [J].
PHILLIPS, TR ;
TALBOTT, RL ;
LAMONT, C ;
MUIR, S ;
LOVELACE, K ;
ELDER, JH .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4605-4613
[8]   INFECTIVITY OF RETROVIRAL DNA INVIVO [J].
PORTIS, JL ;
MCATEE, FJ ;
KAYMAN, SC .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (12) :1272-1273
[9]   INTRADERMAL GENE IMMUNIZATION - THE POSSIBLE ROLE OF DNA UPTAKE IN THE INDUCTION OF CELLULAR-IMMUNITY TO VIRUSES [J].
RAZ, E ;
CARSON, DA ;
PARKER, SE ;
PARR, TB ;
ABAI, AM ;
AICHINGER, G ;
GROMKOWSKI, SH ;
SINGH, M ;
LEW, D ;
YANKAUCKAS, MA ;
BAIRD, SM ;
RHODES, GH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9519-9523
[10]  
Sambrook J., 2002, MOL CLONING LAB MANU